BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2330942)

  • 1. Acute scleritis in porphyria cutanea tarda.
    Salmon JF; Strauss PC; Todd G; Murray AD
    Am J Ophthalmol; 1990 Apr; 109(4):400-6. PubMed ID: 2330942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five cases of porphyria cutanea tarda with mild cutaneous changes: evaluation of the efficacy of phlebotomy by the pattern analysis of urinary porphyrins.
    Nonaka S; Ohgami T; Murayama F; Yamashita K; Yoshida H
    J Dermatol; 1986 Jun; 13(3):196-202. PubMed ID: 3537046
    [No Abstract]   [Full Text] [Related]  

  • 3. ACQUIRED PORPHYRIA CUTANEA TARDA: REPORT OF A CASE SUCCESSFULLY TREATED BY PHLEBOTOMY.
    KOVAL A; DANBY CW; PETERMANN H
    Can Med Assoc J; 1965 Sep; 93(10):537-40. PubMed ID: 14341652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of phlebotomy on urinary porphyrin pattern and liver histology in patients with porphyria cutanea tarda.
    Di Padova C; Marchesi L; Cainelli T; Gori G; Podenzani SA; Rovagnati P; Rizzardini M; Cantoni L
    Am J Med Sci; 1983; 285(1):2-12. PubMed ID: 6824014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerodermoid changes of porphyria cutanea tarda: possible relationship to urinary uroporphyrin levels.
    Friedman SJ; Doyle JA
    J Am Acad Dermatol; 1985 Jul; 13(1):70-4. PubMed ID: 4031154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3 cases of porphyria cutanea tarda--change of urinary porphyrin excretion patterns after phlebotomy].
    Murayama F; Ohgami T; Honda T; Rikimaru M; Hirowatari T; Nonaka S; Yoshida H
    Nihon Hifuka Gakkai Zasshi; 1983 Aug; 93(9):909-15. PubMed ID: 6663799
    [No Abstract]   [Full Text] [Related]  

  • 7. [Association of idiopathic hemochromatosis and tardive cutaneous porphyria].
    Buysschaert M; Verstraeten L; Novik V; Brasseur A; Donckier J; Hassoun A
    Acta Clin Belg; 1991; 46(5):333-7. PubMed ID: 1661554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biochemistry of the regression and latent phase of porphyria cutanea tarda].
    Peschlow I; Schlenzka K
    Dermatol Monatsschr; 1983 Feb; 169(2):85-91. PubMed ID: 6840368
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of treatment of porphyria cutanea tarda with bloodletting and chloroquine].
    Seubert S; Seubert A; Stella AM; Guzman H; Batlle A
    Z Hautkr; 1990 Mar; 65(3):223-5. PubMed ID: 2339575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of porphyria cutanea tarda with intermittent chloroquine].
    Raff M; Formanek I
    Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of bloodletting on the excretion of porphyrius and clelta aminolevulinic acid as well as the clinical picture of porphyria cutanea tarda].
    Broese I; Mattheus A
    Dermatol Monatsschr; 1977 Feb; 163(2):111-8. PubMed ID: 858437
    [No Abstract]   [Full Text] [Related]  

  • 12. Porphyria cutanea tarda in three generations of a single family.
    Benedetto AV; Kushner JP; Taylor JS
    N Engl J Med; 1978 Feb; 298(7):358-62. PubMed ID: 622106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porphyria cutanea tarda. Diagnosis, management, and differentiation from other hepatic porphyrias.
    Grossman ME; Poh-Fitzpatrick MB
    Dermatol Clin; 1986 Apr; 4(2):297-309. PubMed ID: 3955900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pattern of urinary porphyrins in porphyria cutanea tarda].
    Finzi AF
    G Ital Dermatol Venereol; 1984; 119(3):155-6. PubMed ID: 6746007
    [No Abstract]   [Full Text] [Related]  

  • 15. Rare cases of porphyria cutanea tarda associated with additional iron overload.
    Ivanov E; Adjarov D; Kerimova M; Naidenova E
    Dermatologica; 1982 Feb; 164(2):127-32. PubMed ID: 7075851
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary porphyrin analyses in patients with porphyria cutanea tarda.
    Nonaka S; Ogami T; Yoshida K; Honda T; Murayama F; Yoshida H
    J Dermatol; 1982 Oct; 9(5):397-404. PubMed ID: 6761381
    [No Abstract]   [Full Text] [Related]  

  • 17. Patterns of porphyrin-excretion in female estrogen-induced porphyria cutanea tarda.
    Enríquez de Salamanca R; Mingo D; Chinarro S; Muñoz JJ; Perpiñá J
    Arch Dermatol Res; 1982; 274(1-2):179-84. PubMed ID: 7165364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porphyria cutanea tarda. A study of the effect of phlebotomy.
    Epstein JH; Redeker AG
    N Engl J Med; 1968 Dec; 279(24):1301-4. PubMed ID: 5697519
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of porphyria cutanea tarda with chloroquine and phlebotomy.
    Swanbeck G; Wennersten G
    Br J Dermatol; 1977 Jul; 97(1):77-81. PubMed ID: 889703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PORPHYRIA CUTANEA TARDA SYMPTOMATICA (PCT-S): A STUDY OF THE EFFECT OF PHLEBOTOMY THERAPY.
    EPSTEIN JH; REDEKER AG
    Arch Dermatol; 1965 Sep; 92():286-90. PubMed ID: 14329234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.